FDA Regulation and the Dynamic Nature of AI

• by kffconnorg

• September 15, 2026

Neonatal Unit Colonization Pressure and Acquisition of Extended-Spectrum β-Lactamase Gut Colonization

• by Aislinn Cook, Matilda Berkell, C. Henri van Werkhoven, Elske Sieswerda, David R. M. Smith, Chiara Minotti, Liesbet van Heirstraeten, Elias Iosifidis, Emmanuel Roilides, Tuuli Metsvaht, Jose Ignacio Pijoan Zubizarreta, Begoña Loureiro-Gonzalez, Eric Giannoni, Chiara Messina, Surbhi Malhotra-Kumar, Julia Anna Bielicki, NeoIPC Feasibility Group, Jennifer Martin, Filip Djukic, Caridad Tapia-Collados, Eva García-Cantó, Despoina Gkentzi, Eleni Papachatzi, Varvara Dimopoulou, Charles C. Roehr, Paula Brock, Eleftheria Hatzidaki, Nicolina-Hilda Anagnostatou, Eugenio Baraldi, Elena Priante, Kosmas Sarafidis, Angeliki Kontou, Georgios Mitsiakos, Dimitra Gialamprinou, Vassiliki Papaevangelou, Maria Livieratou, Kristin Tanney, Nicola Booth, Donna Tolentino, Amy Reid, Argyro Ftergioti, Maria Simitsopoulou, Kassandra Tataropoulou, Evangelia Koemtzidou, Concepción de Alba Romero, Elena Bergon Sendin, Javier Perez-Lopez, Yolanda Campos-Franco, Aleksandra Pietrzyk, Grete Haube, Mari-Liis Ilmoja, Helgi Padari, Martin Stocker, Alexandra Périsset, Dariusz Gruszfeld, Paul Clarke, Jasmine Myhill, Fernando Cabañas, Mario Giuffrè, Veronica Notarbartolo, Sven Wellmann, Anna Badura

• September 15, 2026

FDA revises monitoring for SCLC therapy

Initial monitoring decreases from 22 to 24 hours to 6 to 8 hours from the start of the first 2 infusions.

• by Kathryn Wighton

• September 15, 2026

• 2 min

Estimate selection determines the apparent mortality threshold at 13 mL/kg/h

• by Shuhao Mei, Hailian Yi, Yuyin Han, Boran Dong, Yong Liu, Xiaoyang Gong

• September 15, 2026